alexa Anti-m?llerian Hormone Deficiency In Females With Inherited Bone Marrow Failure Syndromes
ISSN: 2155-9899

Journal of Clinical & Cellular Immunology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

3rd International Conference and Exhibition on Clinical & Cellular Immunology
September 29-October 01, 2014 DoubleTree by Hilton Baltimore-BWI Airport, USA

Martha M Sklavos, Neelam Giri, Pamela Stratton, Sharon Savage, Blanche P Alter and Ligia A Pinto
ScientificTracks Abstracts: J Clin Cell Immunol
DOI: 10.4172/2155-9899.S1.017
Abstract
Fanconi anemia (FA), dyskeratosiscongenita (DC), and Diamond-Blackfan anemia (DBA) are rare inherited bone marrow failure syndromes (IBMFS) characterized by birth defects, bone marrow failure, and increased frequency of malignancy. Females with FA are known to have a high incidence of infertility which may be associated with primary ovarian insufficiency (POI), while infertility in DC and DBA has not been reported. Anti-M?llerian hormone (AMH) is a marker of ovarian reserve and the decline of AMH is correlated with the loss of fertility as AMH decreases to undetectable levels five to ten years prior to menopause. In this study, we examined whether serum levels of AMH could serve as a menstrual cycle-independent marker for the diagnosis of POI in patients with IBMFS. Serum AMH levels were measured in female participants in the National Cancer Institute?s IBMFS cohort in 22 FA patients (median age 15 years, range 7-37), 20 unaffected FA relatives (age 33.5, range 3-40), 15 patients with DC (age 17, range 4-32), 18 unaffected DC relatives (age 22.5, range 2-40), 12 patients with DBA (age 15.5, range 1-30), 13 unaffected DBA relatives (age 11, range 1-34), and 21 unrelated healthy females (age 27, range 12-40). FA females had very low or undetectable AMH levels (median 0.05 ng/ml, range 0-2.32ng/ml) compared with both unaffected FA relatives (2.10 ng/ml, range 0.04-4.73ng/ml, p<0.0001) and unrelated healthy females (1.92ng/ml, range 0.31-6.64 ng/ml, p<0.0001). All five females with FA over the age of 25 had undetectable AMH levels and were diagnosed with POI. Six of seven FA patients over the age of 20 developed cancer (median age 27; three prevalent, three incident) while all unaffected female relatives and unrelated controls were cancer-free. Females with DC had AMH levels that were significantly lower (0.55 ng/ ml, range 0.01-4.82 ng/ml) than their unaffected relatives (2.33 ng/ml,range0.44-10.03 ng/ml, p=0.001) and unrelated healthy controls (p=0.001) while AMH levels of females with DBA (0.90 ng/ml, range 0-10.20) did not significantly differ from their unaffected relatives (1.71 ng/ml, range: 0.56-5.10 ng/ml, p=0.21) or unrelated healthy controls (p=0.14). One patient with DC reported fertility issues, two patients with DBA were diagnosed with POI, and all three had AMH levels under 1ng/ml. Only one patient with DC had prevalent cancer while DBA patients and all relatives of patients with IBMFS were cancer-free. This study is the first to demonstrate AMH deficiency in females with IBMFS and to suggest that measurement of AMH is useful for the early diagnosis of POI in IBMFS. Our data suggest that AMH may be lower in FA than in DC and DBA. Prior studies indicate that the rates of cancer are highest in FA, followed by DC, and lowest in DBA. Further research is warranted to determine whether there is an association between AMH deficiency and increased cancer risk in IBMFS or within the general (unaffected) population.
Biography
Martha Sklavos earned her undergraduate degree from Johns Hopkins University andher PhD in Immunology from the University Of Pittsburgh School Of Medicine. Currently, Martha is a post-doctoral fellow at the HPV Immunology Laboratory at the Frederick National Laboratory for Cancer Research where she was awarded a grant from the National Cancer Institute to investigate a novel biomarker for cervical cancer risk. She is now leading several studies to define the role of this novel biomarker in additional cancer types. Martha enjoys conceptualizing ideas and driving projects forward and hopes to fill a similar role in the pharmaceutical industry upon completion of her post-doctoral training.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords